Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies.
about
Oral budesonide for induction of remission in ulcerative colitisMedical Therapy of Active Ulcerative ColitisBudesonide Multi-matrix for the Treatment of Patients with Ulcerative ColitisBudesonide MMX(®): a review of its use in patients with mild to moderate ulcerative colitis.Emerging Treatment Options in Mild to Moderate Ulcerative Colitis.Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.Current and Future Targets for Mucosal Healing in Inflammatory Bowel Disease.Optimizing pharmacologic management of inflammatory bowel disease.Budesonide for the treatment of ulcerative colitis.Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis.MMX® technology and its applications in gastrointestinal diseases.Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challengesModified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.Improving IBD Care: A Personalized Approach to Management.Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy-Access to Rapid Treatment (iSTART) approach
P2860
Q24186368-38943D89-65CA-43AE-B3B0-29B05C88291EQ26777729-021FD623-F40D-4799-9AA4-8BC05B862FC7Q26779042-C32B52BC-4084-4F37-A8FE-0A84B2D7CD6FQ34474024-2AFDDD5C-836D-4FDD-84C8-7D51756CCDBBQ36172156-F50D14AB-6D14-4D11-A7E0-5E093426C89FQ36919671-76260764-00B0-41B1-9641-65A93BCE12E2Q38501680-DE126F1B-73E8-4725-9020-5542E00150E7Q38671272-322CF4F9-3A27-41C4-961D-E2CC5F3D8932Q38687407-93DC42F2-97C3-4133-B67A-E0D22978B054Q38828972-1406FB55-F749-499B-82A5-6C4EDCE41484Q38960072-825F71DB-5649-47DA-B193-EA272F30FC91Q40095211-610CD33D-E792-47DE-B1A3-E8AD982542A7Q42375646-C047DCF3-9DF0-4367-A796-2717FB3D2F53Q45937561-2517A6A6-FD13-4E67-8D22-16DB0C7126F1Q55512056-151117F8-2932-495B-9709-C60662697A33Q57457834-D8D4CFA6-50FB-40F9-A2F3-9A1D804F1457
P2860
Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Induction of clinical and colo ...... alysis of two phase 3 studies.
@en
type
label
Induction of clinical and colo ...... alysis of two phase 3 studies.
@en
prefLabel
Induction of clinical and colo ...... alysis of two phase 3 studies.
@en
P2093
P2860
P356
P1476
Induction of clinical and colo ...... nalysis of two phase 3 studies
@en
P2093
E David Ballard
W J Sandborn
P2860
P304
P356
10.1111/APT.13076
P407
P577
2015-01-15T00:00:00Z